PLD-106

N/A

Report date: 2025/03/10 10:30:57
NME

Base Information

Drug NamePLD-106
Drug Alias NamePLD-106
ClassificationOther
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Renal CellCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPelemed Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPelemed Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Renal CellCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A